PharmaResearch (Pharmaceuticals) Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Public

  • Employees
  • 470

Employees

  • Stock Symbol
  • 214450

Stock Symbol

  • Investments
  • 6

  • Share Price
  • $188.10
  • (As of Friday Closing)

PharmaResearch (Pharmaceuticals) General Information

Description

PharmaResearch Co Ltd formerly Pharma Research Products Co Ltd is a bio pharmaceutical firm which realizes a new treatment paradigm for regenerative medicine. Its products include Rejuran, Rejuvenex, and Re-An eye drops. It also provides medical devices, cosme ceuticals, and dietary supplements.

Contact Information

Formerly Known As
Pharma Research Products
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 77-19, Gwahakdanji-ro
  • Gangneung, Gangwon 25452
  • South Korea
+82
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Stock Exchange
KRX
Corporate Office
  • 77-19, Gwahakdanji-ro
  • Gangneung, Gangwon 25452
  • South Korea
+82

PharmaResearch (Pharmaceuticals) Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PharmaResearch (Pharmaceuticals) Stock Performance

As of 13-Nov-2026, PharmaResearch (Pharmaceuticals)’s stock price is $188.10. Its current market cap is $1.95B with 10.4M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$188.10 $185.15 $153.50 - $391.93 $1.95B 10.4M 105K $12.32

PharmaResearch (Pharmaceuticals) Financials Summary

As of 30-Jun-2026, PharmaResearch (Pharmaceuticals) has a trailing 12-month revenue of $416M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 2,197,001 2,703,373 1,737,883 763,439
Revenue 415,900 376,836 256,600 199,634
EBITDA 183,392 159,148 90,820 82,821
Net Income 127,951 116,026 67,459 58,550
Total Assets 717,543 724,918 580,935 415,372
Total Debt 8,900 7,288 9,598 26,018
Public Fundamental Data provided by Morningstar, Inc. disclaimer

PharmaResearch (Pharmaceuticals) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PharmaResearch (Pharmaceuticals)‘s full profile, request access.

Request a free trial

PharmaResearch (Pharmaceuticals) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PharmaResearch (Pharmaceuticals) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore PharmaResearch (Pharmaceuticals)‘s full profile, request access.

Request a free trial

PharmaResearch (Pharmaceuticals) Investments & Acquisitions (6)

PharmaResearch (Pharmaceuticals)’s most recent deal was a Merger/Acquisition with Cosmetic Group USA. The deal was made on 30-Jun-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Cosmetic Group USA 30-Jun-2026 Merger/Acquisition BPO/Outsource Services
Connext 16-Mar-2026 Later Stage VC Biotechnology
TURINGBIO 10-Jul-2024 Merger/Acquisition Other Healthcare Technology Systems
Promore Pharma 06-Jul-2017 IPO Drug Discovery
DrJSkinClinic 13-Jun-2016 Merger/Acquisition Personal Products
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

PharmaResearch (Pharmaceuticals) ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

35.75 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Biotechnology

Subindustry

of 431

Rank

Percentile

To view PharmaResearch (Pharmaceuticals)’s complete esg history, request access »

PharmaResearch (Pharmaceuticals) Exits (2)

PharmaResearch (Pharmaceuticals)’s most recent exit was on 06-Jul-2017 from Promore Pharma. The exit was categorized as with 3 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Promore Pharma 06-Jul-2017 Completed
  • 3 buyers
Promore Pharma Early Stage VC Completed
  • 3 buyers
To view PharmaResearch (Pharmaceuticals)’s complete exits history, request access »

PharmaResearch (Pharmaceuticals) Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
TURINGBIO Seongnam, South Korea 2020
DrJSkinClinic Cerritos, CA 2000

PharmaResearch (Pharmaceuticals) FAQs

  • When was PharmaResearch (Pharmaceuticals) founded?

    PharmaResearch (Pharmaceuticals) was founded in 1993.

  • Where is PharmaResearch (Pharmaceuticals) headquartered?

    PharmaResearch (Pharmaceuticals) is headquartered in Gangneung, South Korea.

  • What is the size of PharmaResearch (Pharmaceuticals)?

    PharmaResearch (Pharmaceuticals) has 470 total employees.

  • What industry is PharmaResearch (Pharmaceuticals) in?

    PharmaResearch (Pharmaceuticals)’s primary industry is Pharmaceuticals.

  • Is PharmaResearch (Pharmaceuticals) a private or public company?

    PharmaResearch (Pharmaceuticals) is a Public company.

  • What is PharmaResearch (Pharmaceuticals)’s stock symbol?

    The ticker symbol for PharmaResearch (Pharmaceuticals) is 214450.

  • What is the current stock price of PharmaResearch (Pharmaceuticals)?

    As of 13-Nov-2026 the stock price of PharmaResearch (Pharmaceuticals) is $188.10.

  • What is the current market cap of PharmaResearch (Pharmaceuticals)?

    The current market capitalization of PharmaResearch (Pharmaceuticals) is $1.95B.

  • What is PharmaResearch (Pharmaceuticals)’s current revenue?

    The trailing twelve month revenue for PharmaResearch (Pharmaceuticals) is $416M.

  • What is PharmaResearch (Pharmaceuticals)’s annual earnings per share (EPS)?

    PharmaResearch (Pharmaceuticals)’s EPS for 12 months was $12.32.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process